Stay updated on Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial page.

Latest updates to the Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added, and the funding lapse notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding with links to cc.nih.gov and opm.gov, and updated the page version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedUI and editorial updates include a Show glossary control, capitalization corrections in labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and an updated revision indicator to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedMinor revision tag updated from v3.3.3 to v3.3.4; there are no changes to study information or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page adds a Locations section with Washington as a location and removes the HHS Vulnerability Disclosure entry. The page revision is updated to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Radiation in Soft Tissue Sarcoma Clinical Trial page.